Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Toxins|December 24, 2025
Targeting the Gut-Kidney Axis: Modulation of Gut Microbiota by Traditional Chinese Medicine for Chronic Kidney Disease ManagementYijing Xin, Libin PanSoft Matter|August 14, 2018
Co-assemblies of polydiacetylenes and metal ions for solvent sensingSi Wu, Libin Pan, Youju Huang, et al.Cancers|May 4, 2026
Gut Microbiota Metabolic Reprogramming Drives Endocrine and Immune Resistance in Hormone-Dependent CancersZhengqin Zhu, Yiting Yang, Libin Pan, et al.Toxicology and Applied Pharmacology|February 6, 2026
Multi-omics reveal the key role of gut microbiota metabolism in adenine-induced chronic kidney diseaseYijing Xin, Hui Ma, Xiang Li, et al.International Journal of Oncology|August 2, 2024
Current development of molecular classifications of gastric cancer based on omics (Review)Yubo Ma, Zhengchen Jiang, Libin Pan, et al.Journal of Oral Microbiology|April 10, 2025
Tongue coating microbiota-based machine learning for diagnosing digestive system tumoursYubo Ma, Zhengchen Jiang, Yanan Wang, et al.Frontiers in Pharmacology|March 20, 2023
Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathwayJing Zhao, Yunfu Shi, Yubo Ma, et al.Journal of Oral Microbiology|August 20, 2024
Oral microbiota and gastric cancer: recent highlights and knowledge gapsRuihong Xia, Zhengchen Jiang, Ying Zhou, et al.Toxicology and Applied Pharmacology|November 9, 2025
Metformin alleviates ribociclib-induced lung injury by restoring impaired autophagy via targeting Mucolipin-1Yueping Qiu, Jing Chen, Yu Zhang, et al.Acta Pharmaceutica Sinica. B|May 4, 2023
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiotaLibin Pan, Hang Yu, Jie Fu, et al.Pageof 2